Importance of the pharmacokinetics of valproic acid in an individualized approach to the treatment of epileptic women of fertile age

被引：0

作者：

Shnaider N.A. ^{[1
]}

Sychev D.A. ^{[2
]}

Pilyugina M.S. ^{[1
]}

Dmitrenko D.V. ^{[1
]}

Bochanova E.N. ^{[1
]}

机构：

[1] V. F. Voino-Yasenetskii Krasnoyarsk State Medical University,

[2] I. M. Sechenov First Moscow State Medical University,undefined

来源：

Neuroscience and Behavioral Physiology | 2012年 / 42卷 / 9期

基金：

中国国家自然科学基金;

关键词：

Epilepsy; Folic acid antagonist; Pharmacokinetics; Valproic acid; Women;

D O I：

10.1007/s11055-012-9663-2

中图分类号：

学科分类号：

摘要：

A clinical case of the development of therapeutic side effects in an epileptic woman of childbearing age is presented. The development of therapeutic side effects occurred on the background of an intermediate therapeutic dose of a valproic acid formulation and was associated with primary (idiopathic) and secondary (valproate-induced) impairments to the folate cycle on the background of a combination of a polymorphism in the CYP2C9*3 gene and a mutation in the MTHFR gene. © 2012 Springer Science+Business Media New York.

引用

页码：963 / 968

页数：5

共 24 条

[1] 607093
[2] Baranov V.S., Baranova E.V., Ivashchenko T.E., Aseev M.V., The Human Genome and 'Predisposition' Genes. Introduction to Predictive Medicine, (2000)
[3] Belousov Yu.B., Gekht A.B., Milchakova L.E., Et Al., Clinicaleconomic efficacy of the treatment of patients with epilepsy, Qualitative Clinical Practice, (2002)
[4] Karlov V.A., Epilepsy in Children and Adults, Women and Men: Guidelines for Physicians, (2010)
[5] Kukes V.G., Sychev D.A., Shikh E.V., Studies of the drug biotransformation - A pathway to increasing the efficacy and safety of drug treatment, Vrach, 1, pp. 6-8, (2007)
[6] Kukes V.G., Grachev S.V., Sychev D.A., Ramenskaya G.V., Drug Metabolism. The Scientific Grounds for Personalized Medicine: Guidelines for Physicians, (2008)
[7] Pilyugina M.S., Pathways of the metabolism of valproic acid formulations and carbamazapine, Vestn. Kin. Boln., 51, 3-10, pp. 52-55, (2010)
[8] Sychev D.A., Ramenskaya G.V., Ignatiev I.V., Kukus V.G., Clinical Pharmacogenetics, (2007)
[9] Shnaider N.A., Pilyugina M.S., Dmitrenko D.V., Et Al., A personalized approach to the treatment of epilepsy - A pathway to decreasing cases of drug resistance, Biomeditsina, 3, pp. 172-174, (2010)
[10] Shnaider N.A., Pilyugina M.S., Dmitrenko D.V., Et Al., An individual approach to the selection of antiepileptic treatment and the clinical pharmacological monitoring of anticonvulsants - A pathway to rational drug use, Klin. Farmakol. Ter., 6, pp. 178-180, (2010)

← 1 2 3 →